Apex Biotechnology Corp. (TPE:1733)
28.00
-0.70 (-2.44%)
Nov 20, 2026, 1:30 PM CST
| Market Cap | 2.80B -7.0% |
| Revenue (ttm) | 1.86B -5.2% |
| Net Income | 185.61M +22.7% |
| EPS | 1.85 +23.4% |
| Shares Out | 99.95M |
| PE Ratio | 15.13 |
| Forward PE | n/a |
| Dividend | 1.30 (4.64%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 202,022 |
| Open | 28.55 |
| Previous Close | 28.70 |
| Day's Range | 28.00 - 28.75 |
| 52-Week Range | 28.00 - 33.10 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 15, 2027 |